Abstract:Fibronectin type III domain containing 4 (FNDC4) is highly homologous with FNDC5, which possesses various cardiometabolic protective functions. Emerging evidence suggests a noteworthy involvement of FNDC4 in fat metabolism and inflammatory processes. This study aimed to characterize the role of FNDC4 in myocardial ischemia/reperfusion (MI/R) injury and decrypt its underlying mechanisms. MI/R models of mice were established to investigate the alteration of FNDC4 in plasma and myocardium. We observed plasma FNDC4 in MI/R-injury mice and patients experiencing acute myocardial infarction were both significantly reduced as opposed to their respective controls. Likewise, FNDC4 expression of myocardium decreased markedly in MI/R mice compared to the sham-operated group. Mice of FNDC4 knockout and myocardial overexpression were further introduced to elucidate the role of FNDC4 in MI/R injury by detecting cardiomyocyte apoptosis, myocardial infarct size, and cardiac function. Ablation of FNDC4 exacerbated cardiac dysfunction, increased myocardial infarction area and cardiomyocyte apoptosis when matched with wild-type mice post-MI/R. In contrast, FNDC4 overexpression through intramyocardial injection of rAAV9-Fndc4 significantly ameliorated cardiac function, reduced myocardial infarction area and cardiomyocyte apoptosis compared to sham group. Additionally, hypoxia-reoxygenation (H/R) was used to induce cardiomyocyte apoptosis, and to further elucidate the direct effects of FNDC4 on cardiomyocytes in vitro, and the results demonstrated that neonatal rat ventricular cardiomyocytes overexpressing FNDC4 showed less H/R-induced apoptosis, as evidenced by cleaved caspase 3 expression, TUNEL staining and flow cytometry. By performing RNA-seq analysis followed by cause-effect analysis, ERK1/2-Nrf2 pathway-mediated antioxidative effects were responsible for the protective roles of FNDC4 on cardiomyocytes. In summary, FNDC4 exerts cardioprotection against MI/R injury predominantly through mitigating oxidative stress responses and reducing cardiomyocyte apoptosis. These insights solidify the proposition of FNDC4 as a potential therapeutic aim for tackling MI/R damage.

Upregulation of FAM129B protects cardiomyocytes from hypoxia/reoxygenation‐induced injury by inhibiting apoptosis, oxidative stress, and inflammatory response via enhancing Nrf2/ ARE activation

Knock-down of Farnesyl Pyrophosphate Synthase Protects Heart-Derived H9c2 Cells Against Hypoxia/reoxygenation-Induced Injury.

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

The Protective Role of Bfgf in Myocardial Infarction and Hypoxia Cardiomyocytes by Reducing Oxidative Stress Via Nrf2

Knockdown of Long Non-Coding Rna-Zfas1 Protects Cardiomyocytes Against Acute Myocardial Infarction Via Anti-Apoptosis by Regulating Mir-150/Crp

DBC-1 contributes to the cardiomyocyte apoptosis via increasing TNF-α-induced activation of p38-caspase8 pathways after myocardium ischemia reperfusion

FAT10 protects cardiac myocytes against apoptosis.

Anti-apoptotic effects of myocardin-related transcription factor-A on rat cardiomyocytes following hypoxia-induced injury

Overexpression of FGF19 Alleviates Hypoxia/reoxygenation-Induced Injury of Cardiomyocytes by Regulating GSK-3β/Nrf2/ARE Signaling.

Asiatic Acid Enhances Survival of Human Ac16 Cardiomyocytes under Hypoxia by Upregulating Mir-1290

MiR-129-5p protects H9c2 cardiac myoblasts from hypoxia/reoxygenation injury by targeting TRPM7 and inhibiting NLRP3 inflammasome activation

Ubiquitin-like protein fat10 protects cardiac myocytes against apoptosis

Nuclear respiratory factor 1 protects H9C2 cells against hypoxia‐induced apoptosis via the death receptor pathway and mitochondrial pathway

Mir-129-5p Ameliorates Ischemia-Reperfusion Injury by Targeting HMGB1 in Myocardium.

FAM3A Mediates PPARγ's Protection in Liver Ischemia-Reperfusion Injury by Activating Akt Survival Pathway and Repressing Inflammation and Oxidative Stress

Up-regulation of CTRP12 Ameliorates Hypoxia/re-Oxygenation-induced Cardiomyocyte Injury by Inhibiting Apoptosis, Oxidative Stress, and Inflammation Via the Enhancement of Nrf2 Signaling.

Upregulation of Iaspp Ameliorates Hypoxia/reoxygenation-Induced Apoptosis and Oxidative Stress in Cardiomyocytes by Upregulating Nrf2 Signaling

Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury Via MicroRNA-106a-5p and MicroRNA-106b-5p

Fibronectin Type Iii Domain Containing 4 Alleviates Myocardial Ischemia/Reperfusion Injury Viathe Nrf2-Dependent Antioxidant Pathway

Increased Expression Of Rp105 Decreases Cardiomyocytes Hypoxia/Reoxygenation Injury Through The Tlr4/Nf-Kappa B Signaling Pathway

Beta-1-Adrenergic Receptors Mediate Nrf2-HO-1-HMGB1 Axis Regulation to Attenuate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury in Vitro